dddmag.com
Drug Discovery & Development  

MAGAZINE
Current Issue
Archives
Upcoming Issues
Advisory Board
Contribute
Meet the Staff






SITE SPONSORS 










Advertise with Us
 


IDBS Acquires Quantrix
Drug Discovery & Development - August 26, 2010

IDBS, a worldwide provider of data management and analytics solutions to healthcare organizations, announced that it has concluded an agreement to acquire Quantrix, an award-winning company that provides business modeling and analytics software and services. As part of the cash acquisition, Quantrix will continue to operate as an independent business unit from its headquarters in Portland, Maine, USA.

The acquisition is a strategic step forward in the longstanding relationship between the companies. Quantrix technology is licensed for use within one of IDBS’ leading products, E-WorkBook Suite, the industry leading scientific electronic laboratory notebook. Quantrix has customers across 50 countries in markets including financial services, manufacturing and engineering.

“We are pleased to be able to welcome Quantrix into the IDBS group,” says Neil Kipling, founder and CEO of IDBS. “This transaction allows us to accelerate the introduction of advanced modeling and analytics tools into our solutions for high value areas in pharmaceutical and healthcare informatics, such as translational medicine and preclinical development. IDBS also recognizes the value of Quantrix technology for a broad range of vertical markets, such as financial services, engineering and manufacturing and will continue to invest in its ongoing development and commercialization.”

"Joining IDBS will significantly benefit our customers and partners by enabling Quantrix to devote additional resources toward the development and marketing of our suite of integrated solutions that improve business decision-making," says Chris Houle, who continues as CEO of Quantrix. "This partnership supports our vision of enhancing business performance by replacing error-prone spreadsheets and overly complex and expensive enterprise business intelligence software with integrated business modeling and analytics solutions.”

This transaction comes one year after the acquisition of InforSense by IDBS which has already led to the release of new biomarker and diagnostics discovery applications which combine scientific data management and analytics. In 2010 IDBS was listed in the 2010 Sunday Times PricewaterhouseCoopers Profit Track 100 list of companies.

Date: August 26, 2010
Source: IDBS 






Most Popular




DDD subscription

Free Drug Discovery & Development
Industry Subscriptions

Magazine

Drug Discovery & Development Magazine

Newsletters

newsletters

Sign up now

 

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter